The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1

• Published in: Biochemical and biophysical research communications Vol. 635; pp. 194 - 202
• Main Authors: Sameri, Maryam J., Savari, Feryal, Hoseinynejad, Khojasteh, Danyaei, Amir, Mard, Seyed Ali
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 20-12-2022
• Subjects: Animals; Apoptosis; Exosomes; Exosomes - pathology; H2S; Huc-MSC; Humans; Ischemia - pathology; Liver - pathology; Liver injury; Male; Mesenchymal Stem Cells; Mice; Reperfusion Injury - pathology; Reperfusion Injury - prevention & control; RNA, Long Noncoding; Sodium hydrosulfide (NaHS); IRI; Sodium hydrosulfide (NaHS); Huc-MSC; H2S; Exosomes; MSC; Apoptosis; Liver injury
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2022.09.111

Ischemia-reperfusion injury (IRI) by causing histopathological changes is considered one of the most important causes of liver failure and dysfunction after surgery which affect graft outcomes. Stem cells are new promising approaches to treating different diseases. One of the critical strategies to improve their function is the preconditioning of their culture medium. This study compared the effect of NaHS-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice. Methods: Human umbilical cord-derived MSC (MSC) cultured in a 75 cm3 flask and when confluency reached about 80%, the culture medium replaced with a serum-free medium, and 48 h later supernatants collected, concentrated, and then MSC-Exo extracted. To obtain H2S-Exo, MSC was treated with NaHS (1 μmol),the supernatant collected after 48 h, concentrated and exosomes extracted. Twenty-four male mice were randomly divided into four groups (n = 6) including: 1-ischemia, 2-sham-operated, 3- MSC-Exo, and 4- H2S-Exo. To induce ischemia, the hepatic artery and portal vein clamped using an atraumatic clip for 60 min followed by 3 h of reperfusion. Just upon ending the time of ischemia (removal of clamp artery), animals in MSC-Exo, and H2S-Exo groups received 100 μg exosomes in 100 μl PBS via tail vein. At the end of reperfusion, blood, and liver samples were collected for further serological, molecular, and histological analyses.
Administration of both MSC-Exo and H2S-Exo improved liver function by reducing inflammatory cytokines, cellular apoptosis, liver levels of total oxidant status, and liver aminotransferases. The results showed that protecting effect of MSC exosomes enhanced following NaHS preconditioning of cell culture medium.
MSC-Exo and H2S-Exo had hepato-protective effects against injuries induced by ischemia-reperfusion in mice. NaHS preconditioning of mesenchymal stem cells could enhance the therapeutic effects of MSC-derived exosomes.
[Display omitted]
•Sodium hydrosulfide (NaHS) preconditioning of MSC increase their cell viability.•H2S -modified MSC-Exosomes, reduce the expression of pro-inflammatory cytokines in liver ischemia-reperfusion injury.•MSC-exosomes decrease apoptosis by preventing BAK1/BAX dimerization and inhibiting NF-κB.•The LncMALAT1 expression level reduce following liver ischemia-reperfusion injury